Testing a new deworming drug for whipworm
Treatments studied
Part of Infections clinical trials.
This trial is testing a new deworming drug called emodepside for people with whipworm infections. It aims to see if emodepside is safe and effective at clearing the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have a whipworm infection, with or without other worms like hookworm or roundworm, confirmed by stool tests.
- You have not taken any deworming medicine (like albendazole, mebendazole, or ivermectin) in the last 28 days.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.
- You do not have serious liver, kidney, or other health problems, and you are not taking certain medications that could interfere with the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called emodepside to treat infections caused by intestinal worms like whipworm, hookworm, and roundworm. It may help people who have not been cured by standard treatments.
This study tests new combinations of deworming medicines to treat whipworm infection in school-aged children in Honduras. It aims to find a more effective treatment for children with this parasitic infection.
This early-phase study tests whether deliberately infecting you with hookworm larvae placed on the skin is safe and how your body responds. It may help researchers understand treatments for hookworm-related conditions, but it involves being intentionally infected.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
This trial tests a new drug, emodepside, against the standard treatment albendazole for whipworm infection. It aims to see which is safer and works better in adolescents and adults.
This trial tests whether oxfendazole can better treat whipworm (Trichuris trichiura) in adults by checking stool samples before and after treatment. You may be eligible if you’ve recently had whipworm found in stool and can return for multiple follow-up samples.
Hear when a new Trichuris Trichiura; Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.